These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 29354117)

  • 1. Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane.
    Foster TL; Pickering S; Neil SJD
    Front Immunol; 2017; 8():1853. PubMed ID: 29354117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.
    Tokarev A; Skasko M; Fitzpatrick K; Guatelli J
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1197-210. PubMed ID: 19929170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
    Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
    J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding restriction factors and intrinsic immunity: insights and lessons from the primate lentiviruses.
    Kirmaier A; Krupp A; Johnson WE
    Future Virol; 2014; 9(5):483-497. PubMed ID: 26543491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BST-2/tetherin: a new component of the innate immune response to enveloped viruses.
    Evans DT; Serra-Moreno R; Singh RK; Guatelli JC
    Trends Microbiol; 2010 Sep; 18(9):388-96. PubMed ID: 20688520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.
    Dufrasne FE; Lombard C; Goubau P; Ruelle J
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27754450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction of Retroviral Replication by Tetherin/BST-2.
    Hammonds J; Wang JJ; Spearman P
    Mol Biol Int; 2012; 2012():424768. PubMed ID: 22811908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counteraction of the multifunctional restriction factor tetherin.
    Sauter D
    Front Microbiol; 2014; 5():163. PubMed ID: 24782851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells.
    Strauss JD; Hammonds JE; Yi H; Ding L; Spearman P; Wright ER
    J Virol; 2016 Feb; 90(3):1507-21. PubMed ID: 26582000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Vertebrate Evolution of the Host Restriction Factor Tetherin.
    Heusinger E; Kluge SF; Kirchhoff F; Sauter D
    J Virol; 2015 Dec; 89(23):12154-65. PubMed ID: 26401043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation.
    Janvier K; Pelchen-Matthews A; Renaud JB; Caillet M; Marsh M; Berlioz-Torrent C
    PLoS Pathog; 2011 Feb; 7(2):e1001265. PubMed ID: 21304933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.
    Fitzpatrick K; Skasko M; Deerinck TJ; Crum J; Ellisman MH; Guatelli J
    PLoS Pathog; 2010 Mar; 6(3):e1000701. PubMed ID: 20221443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Activity and Adaptive Evolution of Avian Tetherins.
    Krchlíková V; Fábryová H; Hron T; Young JM; Koslová A; Hejnar J; Strebel K; Elleder D
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32238588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human BST-2/tetherin inhibits Junin virus release from host cells and its inhibition is partially counteracted by viral nucleoprotein.
    Zadeh VR; Urata S; Sakaguchi M; Yasuda J
    J Gen Virol; 2020 Jun; 101(6):573-586. PubMed ID: 32375950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells.
    Jolly C; Booth NJ; Neil SJ
    J Virol; 2010 Dec; 84(23):12185-99. PubMed ID: 20861257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.
    Heusinger E; Deppe K; Sette P; Krapp C; Kmiec D; Kluge SF; Marx PA; Apetrei C; Kirchhoff F; Sauter D
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.
    Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic-Like Virus Budding in Archaea.
    Quemin ER; Chlanda P; Sachse M; Forterre P; Prangishvili D; Krupovic M
    mBio; 2016 Sep; 7(5):. PubMed ID: 27624130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV.
    VandeWoude S; Troyer J; Poss M
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):25-32. PubMed ID: 19896218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.